The importance of target validation in drug discovery and development
Lowe, J.A.; Jones, P.; Wilson, D.M.
Current Opinion in Drug Discovery and Development 12(5): 581-584
2009
ISSN/ISBN: 1367-6733 PMID: 19736617 Document Number: 632231
Document emailed within 1 workday
Related Documents
Lavery, K.S.; King, T.H. 2003: Antisense and RNAi: powerful tools in drug target discovery and validation Current Opinion in Drug Discovery and Development 6(4): 561-569Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Imaizumi, Y.; Kaneko, S. 2011: Study on ion channel transporters as a target for the drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(6): 227
Płocinska, R.; Korycka-Machala, M.; Plocinski, P.; Dziadek, J. 2017: Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery Current Topics in Medicinal Chemistry 17(19): 2129-2142
Haramura, M. 2007: Application of chemical biology to proteomics in drug target discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(2): 124-128
Golz, S.; Jörg Hüser 2007: Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening Clinical Laboratory 53(1-2): 77-79
Garvey, R. 2006: Target specific seminars in drug discovery--IBC conference. 24-26 April 2006, Berlin, Germany IDrugs: the investigational drugs journal 9(7): 474-475
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Kaur, N.; Sharma, A.K.; Shakeel, A.; Kumar, V.; Singh, A.; Gupta, A.; Suhag, D.; Rajput, S.K.; Mukherjee, M. 2017: Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery Current Topics in Medicinal Chemistry 17(22): 2495-2508
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
McGowan, J.; Hoth, D. 1989: AIDS drug discovery and development Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
Lucignani, G.; Bastianello, S. 2007: Pharmacological MRI: a biomarker in CNS drug discovery and development? Functional Neurology 22(2): 71-73
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Amanfu, R.K.; Saucerman, J.J. 2011: Cardiac models in drug discovery and development: a review Critical Reviews in Biomedical Engineering 39(5): 379-395
Yamada, H. 2013: Application of translational research to drug discovery and development Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(3): 121
2006: NIAID researchers make key discovery in development of TB drug candidate Journal of investigative medicine: the official publication of the American Federation for Clinical Research 54(2): 53-54
Nassar, A-Eldin.F.; Lopez-Anaya, A. 2004: Strategies for dealing with reactive intermediates in drug discovery and development Current Opinion in Drug Discovery and Development 7(1): 126-136
Srivastava, P.; Tiwari, A. 2017: Critical Role of Computer Simulations in Drug Discovery and Development Current Topics in Medicinal Chemistry 17(21): 2422-2432
Wunder, A.; Thiele, A.; Koslowski, M.; Gantner, F.; Niessen, H. 2014: Nuclear imaging to support anti-inflammatory drug discovery and development Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 2014